# Effects of MRSA Bactericidal Gel To Promote Healing and Eliminate MRSA in cSSTI Vancogel(TM)

> **NCT00945152** · PHASE2 · UNKNOWN · sponsor: **Robert S Berman MD** · enrollment: 100 (estimated)

## Conditions studied

- Bacterial Infections
- Wounds

## Interventions

- **DRUG:** Vancomycin 1.25-1.50% in a complex gel formulation trademarked Vancogel(R)
- **DRUG:** Placebo, complex gel formulation without Vancomycin

## Key facts

- **NCT ID:** NCT00945152
- **Lead sponsor:** Robert S Berman MD
- **Sponsor class:** OTHER
- **Phase:** PHASE2
- **Study type:** INTERVENTIONAL
- **Status:** UNKNOWN
- **Start date:** 2011-07-15
- **Primary completion:** 2024-12-15
- **Final completion:** 2024-12-15
- **Target enrollment:** 100 (ESTIMATED)
- **Last updated:** 2022-07-21


## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT00945152

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT00945152, "Effects of MRSA Bactericidal Gel To Promote Healing and Eliminate MRSA in cSSTI Vancogel(TM)". Retrieved via AI Analytics 2026-05-31 from https://api.ai-analytics.org/clinical/NCT00945152. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*